Contribute Try STAT+ Today

The world has faced a string of infectious disease threats in the past dozen or so years, with SARS, bird flu, swine flu, MERS, and Ebola wreaking havoc.

Yet despite the abundance of evidence that microbes pose major threats, both to human health and economies, global preparedness is not where it needs to be, Dr. Julie Gerberding warned this week.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Let me guess- Merck happens to make compounds that one could use to treat these outbreaks- imagine! What happened to that rule about going o work for a company you used to regulate?

Comments are closed.